Interferon in the prevention of genital herpes recurrence.
Patients with genital herpes were treated three times weekly for 12 weeks with 3 X 10(6) IU of alpha 2b interferon (20 patients) or placebo (17 patients) administered by subcutaneous injection in a double-blind trial. Interferon had minimal effects on the suppression of recurrences and moderate toxi...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1986
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176490/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3789694/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.30.4.608 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|